Global and United States H2-Receptor Antagonists Market Insights, Forecast to 2027

Market Analysis and Insights: Global and United States H2-Receptor Antagonists Market
This report focuses on global and United States H2-Receptor Antagonists market.
In 2020, the global H2-Receptor Antagonists market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the H2-Receptor Antagonists market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global H2-Receptor Antagonists Scope and Market Size
H2-Receptor Antagonists market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H2-Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the H2-Receptor Antagonists market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Ranitidine/Zantac
Cimetidine
Famotidine
Nazatidine

Segment by Application
Retail Stores
Clinics
Hospitals
OTC Sales

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Acic Pharmaceuticals
Actavis Mid Atlantic LLC
Ajanta Pharma
AmerisourceBergen
Amneal Pharmaceuticals
ANDA Repository
Ani Pharmaceuticals
Apotex Inc. (and Apotex Corporation)
Appco Pharma
Aurobindo Pharma
Ben Venue Laboratories Inc.
Boehringer Ingelheim
Breckenridge Pharmaceuticals
Contract Pharmacal Corp.
Dr. Reddy's Laboratories Inc.
Geri-Care Pharmaceuticals
GlaxoSmithKline
Glenmark Pharmaceuticals
Granules Pharmaceuticals Inc.
Heritage Pharma Labs Inc.
Hikma Pharmaceuticals
Hi-Tech Pharmacal Co.
Lannett Co.
Mylan Pharmaceuticals Inc.
Nostrum Laboratories Inc.
Novitium Pharma
PAI Holdings, LLC
Par Pharmaceutical Inc.
Perrigo
Ranbaxy Inc.
Sandoz Inc.
Sanofi-Aventis
Strides
Sun Pharma
Taro Pharmaceuticals
Teva Pharmaceuticals
Thirty Madison
Torrent Pharma
Unique Pharmaceutical Laboratories
VKT Pharma